Efficacy of subcutaneous interferon-beta in COVID-19: a meta-analysis and systematic review
Type 1 interferons, especially interferon-beta, has been reported to be effective in COVID-19 patients in multiple randomized controlled trials. The aim of our meta-analysis and systematic review is to assess efficacy of subcutaneous IFN-beta in regards to mortality and discharge rate. Prospective,...
Main Authors: | Abuzar A. Asif, Habiba Hussain, Sriviji Senthil Kumaran, Salman B. Syed, Varun Vanka, Manisha Tharoor, Umme Salma Rangwala, Urvashi Rathore, Malay Singhal, Tulika Chatterjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Greater Baltimore Medical Center
2021-11-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2021.1984644 |
Similar Items
-
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
by: Mark S. Freedman, et al.
Published: (2024-01-01) -
Extensive subcutaneous emphysema treated with subcutaneous angiocatheters
by: Lena Carleton, et al.
Published: (2023-10-01) -
Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS study
by: Raed Al-Roughani, et al.
Published: (2023-11-01) -
The interferons : characterization and application /
by: Meager, Anthony
Published: (2006) -
Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1
by: Anthony Traboulsee, et al.
Published: (2018-09-01)